Influenza Vaccines for the World

19-21 April 2017, CHUVUniversity of Lausanne, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size


Join the conversation on Twitter – #IVW2017

Influenza Vaccines for the World – IVW 2017 is the sixth international conference and exhibition in this important series of influenza vaccine meetings. The IVW conference series focuses on ‘Influenza Vaccination Issues’.

The IVW series is an international forum for world renowned experts in the field of influenza vaccines and related issues (adjuvants/delivery/vaccination strategies) to report on the latest data and trends associated with current and new influenza vaccines/technologies and their availability/delivery/implementation worldwide.

The IVW 2017 Scientific Advisory Panel invites the influenza community worldwide to submit abstracts for consideration for inclusion in the IVW 2017 oral & poster scientific programmes.

Scientific Advisory Panel

Othmar Engelhardt (NIBSC/HPA, Potters Bar, UK)
Rosalind Hollingsworth (Sanofi Pasteur, Swiftwater, Pennsylvania, USA)
John Oxford (Queen Mary College London / hVIVO Ltd / Oxford Media & Medicine, London, UK)
Albert Osterhaus (University of Veterinary Medicine Hannover, Hannover, Germany)
Ted Ross (University of Georgia, Athens, Georgia, USA)
Yoshihiro Kawaoka (University of Wisconsin, Madison, Wisconsin, USA)
Helen Bright (MedImmune, Liverpool, UK)
Jonathan Van Tam (University of Nottingham, UK)
Rob Lambkin-Williams (hVIVO Ltd., London, UK)
Dirk Poelaert (GSK Vaccines, Wavre, Belgium)
Ronald Kompier (FluConsult, Noordwijk, The Netherlands)
Erin Grace Sparrow (WHO, Geneva, Switzerland)
Manon Cox (Protein Sciences Corporation, Meriden, Connecticut, USA)
Emanuele Montomoli (VisMederi Srl, Siena, Italy)
Yotam Levin (NanoPass Technologies Ltd, Rehovot, Israel)
Manmohan Singh (Takeda Vaccines, Morrisville, North Carolina, USA)
Anna-Karin Maltais (Eurocine Vaccines AB, Solna, Sweden)
Edward Remarque (BPRC, Rijswijk, The Netherlands)
Myra Widjojoatmodjo (Janssen Vaccines, Leiden, The Netherlands)
Sean Tucker (VAXART Inc, South San Francisco, California, USA)
Nathalie Charland (Medicago, Quebec, Canada)
Kathy L. Rowlen (InDevR Inc. Boulder, Colorado, USA)
Shan Lu (University of Massachusetts Medical School, Worcester, Massachusetts, USA)
Carrie Pierce (Centers for Disease Control and Prevention (NCEH/CDC), Atlanta, Georgia, USA)
Jon Bundy (Centers for Disease Control and Prevention (NCEH/CDC), Atlanta, Georgia, USA)
Tamar Ben-Yedidia (BiondVax Pharmaceuticals Ltd, Ness Ziona, Israel)

Conference Scope

IVW 2017 will address the following important topics:

  • Surveillance Issues / Burden of Disease
  • Immunological Issues
  • Social / Political / Financial Issues Surrounding Influenza Vaccination
  • Novel Developments
  • Production / Formulation Issues / Manufacturing Issues
  • Vaccine Usage / Targeting Strategies
  • Influenza Vaccines / Adjuvants – Improvement Issues
  • Pandemic Preparedness Issues / Licensing Issues

The scientific programme will include keynote lectures, contributed papers, workshops, panel discussions, satellite symposia and poster presentations emphasising all aspects of ‘Influenza Vaccines’ and their usage and effectiveness. Potential authors are invited to submit abstracts on any of the above topics for consideration for inclusion within the conference program.

Special Sessions

  • Universal Influenza Vaccines – Latest Developments
  • Innate and Acquired Immunity to Plant-Made Influenza VLP Vaccines in Adults & Elderly
  • IVW 2017 Workshop: Alternative Potency Assay Development for Influenza Vaccines



IVW 2017 Delegates

Login details will be supplied after you have registered for the event.

IVW 2017 Sponsors

  • Vaxart
  • FluConsult
  • MedImmune
  • Eurocine Vaccines
  • VisMederi
  • Nanopass
  • Janssen
  • Sanofi Pasteur
  • InDevR
  • hVIVO
  • MedicaGo
  • Fraunhofer
  • Inovio
  • Biondvax
  • Protein Sciences

IVW 2017 Downloads

IVW 2017 Leaflet

IVW 2017 Mailing List

E-mail Address
What is 3+2-1?